Last edition
News about "inflammatory lung disease"
Insmed's Brinsupri Wins Japan Approval for Non-Cystic Fibrosis Bronchiectasis
Insmed’s Brinsupri (brensocatib) has secured MHLW approval in Japan for non-cystic fibrosis bronchiectasis, expanding access to a new treatment option for patients with the chronic and progressive lung disease.
Inflammatory Lung Disease | 26/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members